Jupiter Neurosciences, INC. (JUNS) — 10-K Filings
All 10-K filings from Jupiter Neurosciences, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Jupiter Neurosciences Pivots to Wellness Amidst Mounting Losses
— Apr 1, 2026 Risk: high
Jupiter Neurosciences, Inc. (JUNS) is a clinical-stage biopharmaceutical company focused on neuroinflammation treatments, primarily targeting Parkinson's Diseas - 10-K Filing — Mar 28, 2025
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX